Table of Content

1. Executive Summary


2. Introduction

2.1 Contract Manufacturing: An Overview

2.1.1 Healthcare CMOs
2.1.2 Healthcare CMOs Market Segments
2.1.3 Pharmaceutical CMOs
Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)
2.1.4 Medical CMOs

2.2 Pharmaceutical Outsourcing: An Overview
2.2.1 Pharmaceutical Outsourcing Market Segments

2.3 Pharmaceutical CMOs v/s CDMOs


3. Global Market Analysis

3.1 Global Healthcare CMO Market Analysis

3.1.1 Global Healthcare CMO Market by Value
3.1.2 Global Healthcare CMO Market by Segments

3.2 Global Healthcare CMO Market: Segment Analysis

3.2.1 Global Medical Device CMO Market by Value
3.2.2 Global Pharmaceutical CMO Market by Value

3.3 Global Pharmaceutical CMO Market Analysis

3.3.1 Global Pharmaceutical CMO Market by Segments
3.3.2 Global Pharmaceutical CMO Market by Region

3.4 Global Pharmaceutical CMO Market: Segment Analysis

3.4.1 Global Active Pharmaceutical Ingredient CMO Market by Value
3.4.2 Global Finished Dosage Formulation CMO Market by Value
3.4.3 Global Other Pharmaceutical Services CMO Market by Value

3.5 Global Pharmaceutical CDMO Market Analysis

3.5.1 Global Pharmaceutical CDMO Market by Value
3.5.2 Global Pharmaceutical CDMO Market by Region


4. Regional Analysis

4.1 The U.S. Pharmaceutical CDMO Market Analysis
4.1.1 The U.S. Pharmaceutical CDMO Market by Value

4.2 Europe Pharmaceutical CDMO Market Analysis
4.2.1 Europe Pharmaceutical CDMO Market by Value

4.3 India Pharmaceutical CDMO Market Analysis
4.3.1 India Pharmaceutical CDMO Market by Value

4.4 China Pharmaceutical CDMO Market Analysis
4.4.1 China Pharmaceutical CDMO Market by Value


5. Competitive Landscape
5.1 Global Healthcare CMO Market Players Financial Comparison


6. Company Profiles

6.1 Catalent, Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy

6.2 Recipharm
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy

6.3 Aurobindo Pharma Limited
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy

6.4 Boehringher Ingelheim
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategy
 



List of Figures



Figure 1: Healthcare CMOs Market Segments
Figure 2: Pharmaceutical Outsourcing Market Segments
Figure 3: Value Chain of a Drug
Figure 4: Global Healthcare CMO Market by Value; 2014-2018 (US$ Billion)
Figure 5: Global Healthcare CMO Market by Value; 2019-2023E (US$ Billion)
Figure 6: Global Healthcare CMO Market by Segments; 2018
Figure 7: Global Medical Device CMO Market by Value; 2014-2018 (US$ Billion)
Figure 8: Global Medical Device CMO Market by Value; 2019-2023E (US$ Billion)
Figure 9: Global Pharmaceutical CMO Market by Value; 2014-2018 (US$ Billion)
Figure 10: Global Pharmaceutical CMO Market by Value; 2019-2023E (US$ Billion)
Figure 11: Global Pharmaceutical CMO Market by Segments; 2018
Figure 12: Global Pharmaceutical CMO Market by Region; 2017
Figure 13: Global Active Pharmaceutical Ingredient CMO Market by Value; 2017-2018 (US$ Billion)
Figure 14: Global Active Pharmaceutical Ingredient CMO Market by Value; 2019-2023 (US$ Billion)
Figure 15: Global Finished Dosage Formulation CMO Market by Value; 2017-2018 (US$ Billion)
Figure 16: Global Finished Dosage Formulation CMO Market by Value; 2019-2023E (US$ Billion)
Figure 17: Global Other Pharmaceutical Services CMO Market by Value; 2017-2018 (US$ Billion)
Figure 18: Global Other Pharmaceutical Services CMO Market by Value; 2019-2023E (US$ Billion)
Figure 19: Global Pharmaceutical CDMO Market by Value; 2014-2018 (US$ Billion)
Figure 20: Global Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Figure 21: Global Pharmaceutical CDMO Market by Region; 2018
Figure 22: The U.S. Pharmaceutical CDMO Market by Value; 2014-2018 (US$ Billion)
Figure 23: The U.S. Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Figure 24: Europe Pharmaceutical CDMO Market by Value; 2014-2018 (US$ Billion)
Figure 25: Europe Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Figure 26: India Pharmaceutical CDMO Market by Value; 2014-2018 (US$ Billion)
Figure 27: India Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Figure 28: China Pharmaceutical CDMO Market by Value; 2014-2018 (US$ Billion)
Figure 29: China Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Figure 30: Catalent Revenue; 2014-2018 (US$ Billion)
Figure 31: Catalent, Inc. Revenue by Segments; 2018
Figure 32: Recipharm Net Sales; 2014-2018 (US$ Million)
Figure 33: Recipharm Net Sales by Segments; 2018
Figure 34: Recipharm Net Sales by Region; 2017
Figure 35: Aurobindo Revenues; 2014-2018 (US$ Billion)
Figure 36: Aurobindo Revenues by Segments; 2018
Figure 37: Boehringher Ingelheim Net Sales; 2013-2017 (US$ Billion)
Figure 38: Boehringher Ingelheim Net Sales by Geography; 2017
Figure 39: Boehringher Ingelheim Net Sales by Business; 2017
Table 1: Global Healthcare CMO Market Players Financial Comparison; 2017-2018